Ghana vs Tunisia: Access to anti-retroviral drugs, male
Ghana
40.0%
in 2024
Tunisia
28.0%
in 2024
Ghana rank
131st
Tunisia rank
133rd
Access to anti-retroviral drugs, male over time
- Ghana
- Tunisia
How they compare
Ghana currently reports 40.0% against 28.0% in Tunisia, a difference of 12.0%.
That makes Ghana's figure about 1.4 times Tunisia's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Tunisia ahead.
Ghana ranks 131st and Tunisia ranks 133rd of 141 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Tunisia in 1.
Head to head by decade
| Decade | Ghana | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 3.7% | 0.4% | Tunisia |
| 2010s | 22.2% | 10.5% | 11.7% | Ghana |
| 2020s | 35.2% | 22.0% | 13.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Ghana or Tunisia?
- Ghana, at 40.0% against 28.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Ghana and Tunisia?
- 12.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and Tunisia rank globally for access to anti-retroviral drugs, male?
- Ghana ranks 131st and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.